LEGAL DISCLAIMER TERMS OF USE

Size: px
Start display at page:

Download "LEGAL DISCLAIMER TERMS OF USE"

Transcription

1 HEDGEYE 1

2 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice to individuals. This research does not constitute an offer to sell, or a solicitation of an offer to buy any security. This research is presented without regard to individual investment preferences or risk parameters; it is general information and does not constitute specific investment advice. This presentation is based on information from sources believed to be reliable. Hedgeye Risk Management is not responsible for errors, inaccuracies or omissions of information. The opinions and conclusions contained in this report are those of Hedgeye Risk Management, and are intended solely for the use of Hedgeye Risk Management s clients and subscribers. In reaching these opinions and conclusions, Hedgeye Risk Management and its employees have relied upon research conducted by Hedgeye Risk Management s employees, which is based upon sources considered credible and reliable within the industry. Hedgeye Risk Management is not responsible for the validity or authenticity of the information upon which it has relied. TERMS OF USE This report is intended solely for the use of its recipient. Re-distribution or republication of this report and its contents are prohibited. For more detail please refer to the appropriate sections of the Hedgeye Services Agreement and the Terms of Use at HEDGEYE 2

3 HEALTHCARE POSITION MONITOR Sentiment Investment Ideas - Longs Trade Trend Tail Sentiment Investment Ideas - Shorts Trade Trend Tail Score 1 LONG Score 1 SHORT 6 ATHN athenahealth, Inc ZBH Zimmer Biomet Holdings, Inc AHS AMN Healthcare Services, Inc MD MEDNAX, Inc. 45 HOLX Hologic, Inc. 24 MDRX Allscripts Healthcare Solutions, Inc. --- Sentiment Long Bench Sentiment Short Bench Score 1 LONG Score 1 SHORT 35 CSLT Castlight Health, Inc. Class B n/a CPHD Cepheid EVH Evolent Health Inc Class A MDSO Medidata Solutions, Inc CERN Cerner Corporation ILMN Illumina, Inc WOOF VCA Inc ICLR ICON Plc CYH Community Health Systems, Inc Q Quintiles Transnational Holdings, Inc CRL Charles River Laboratories International, Inc DVA DaVita HealthCare Partners Inc LPNT LifePoint Health, Inc QSII Quality Systems, Inc LH Laboratory Corporation of America Holdings HCA HCA Holdings, Inc PRXL PAREXEL International Corporation DGX Quest Diagnostics Incorporated CPSI Computer Programs and Systems, Inc DATA SOURCE: FACTSET HEDGEYE 3

4 HEALTHCARE JOLTS SLOWING 50.0% JOLTS: HC Job Openings Rolling 3-Mo YoY % 2-Yr Average 40.0% December % 30.0% 20.0% 10.0% 0.0% April % -10.0% -20.0% -30.0% -40.0% DATA SOURCE: BLS HEDGEYE 4

5 HEALTHCARE JOLTS SLOWING 60.0% JOLTS: HC Job Openings Rolling 3-Mo YoY % ROC 50.0% 40.0% 30.0% April % 20.0% 10.0% 0.0% -10.0% April % -20.0% -30.0% April % -40.0% -50.0% DATA SOURCE: BLS HEDGEYE 5

6 HEALTHCARE JOB OPENINGS (JOLTS) 1,150.0 JOLTS - HC Job Openings Average +1 Std Dev -1 Std Dev 1, DATA SOURCE: BLS HEDGEYE 6

7 HEALTHCARE JOLTS % EMPLOYMENT 3.0x 2.5x HC JOLTS % of HC Employment 2.0x 1.5x 1.0x Z-Score 0.5x 0.0x -0.5x -1.0x -1.5x -2.0x -2.5x DATA SOURCE: BLS HEDGEYE 7

8 HEALTHCARE EMPLOYMENT GAINS Rolling 12-month Healthcare Employment Gains April December Months April March Months DATA SOURCE: BLS HEDGEYE 8

9 HEALTHCARE EMPLOYMENT 4.0% Employment - Health care y/y growth % 3.5% 3.0% May +3.2% 2.5% 2.0% 1.5% 1.0% 0.5% - DATA SOURCE: BLS HEDGEYE 9

10 HEALTHCARE EMPLOYMENT SLOWING 2.0% Rate of Change YoY % Employment Health Care 1.5% 1.0% 0.5% - (0.5%) (1.0%) (1.5%) DATA SOURCE: BLS HEDGEYE 10

11 HOSPITAL EMPLOYMENT 4.5% Employment - Hospitals y/y growth % 4.0% May +3.9% 3.5% 3.0% 2.5% 2.0% 1.5% 1.0% 0.5% - (0.5%) (1.0%) DATA SOURCE: BLS HEDGEYE 11

12 AHS ORGANIC GROWTH FORECAST 35.0% AHS: Total Organic Growth YoY % AHS Organic Growth Forecast - HC Employment Model 30.0% 25.0% Correlation = 0.94 Organic Growth YoY % 20.0% 15.0% 10.0% 5.0% 0.0% -5.0% -10.0% DATA SOURCE: COMPANY FILINGS AND BLS HEDGEYE 12

13 HCA ADMISSIONS VS JOLTS 45.0% 35.0% JOLTS: Health Care and Social Assistance - Job Openings y/y growth % HCA SS Equivalent Admissions (y/y growth %) Correlation = % 7.0% 6.0% JOLTS YoY % 25.0% 15.0% 5.0% 5.0% 4.0% 3.0% 2.0% 1.0% HCA SS AdmissionsYoY% -5.0% 0.0% -1.0% -15.0% -2.0% DATA SOURCE: COMPANY FILINGS AND BLS HEDGEYE 13

14 ATHN LATEST THOUGHTS POSITIVE Winning Hospitals and FQHCs Large Population Health Deals Strong Enterprise Backlog Former AMZN CFO Joins Board Q2/Q4 Active Quarter for Enterprise Deals Valuation Near All Time Low NEGATIVE athena-tracker Slowing Weak Small-Group Bookings / Light Leads Disruption from Streamlined Rollout CFO Departure Other High Level Employee Departures Deteriorating Culture Short Interest Down HEDGEYE 14

15 ATHENA-TRACKER YOY GROWTH 35.0% 30.0% # of medical practices on athenanet 12/4/ % 5/22/ % YoY % Medical Practices on athenanet 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% Note: 8/2014 7/2015 CAGR; 8/2015 Present YoY % DATA SOURCE: HEDGEYE TRACKER HEDGEYE 15

16 ATHN WEEKLY NET NEW ADDITIONS 70 Net New # Net New Medical Practices Q16 Avg Q16 Avg DATA SOURCE: HEDGEYE TRACKER HEDGEYE 16

17 ATHN GLASSDOOR.COM REVIEW DATA SOURCE: GLASSDOOR.COM HEDGEYE 17

18 ATHN STREAMLINED REVIEWS DATA SOURCE: SOFTWAREADVICE.COM AND FACEBOOK HEDGEYE 18

19 ATHN HISTORICAL SHORT INTEREST 40% SI % Float Average +1 Std Dev -1 Std Dev 35% 30% 25% 20% 15% 10% DATA SOURCE: FACTSET HEDGEYE 19

20 ATHN RELATIVE EV/EBITDA S&P x Relative EV/EBITDA SPX Average -1 Std Dev +1 Std Dev 6.0x ATHN NTM EV/EBITDA Relative to SPX 5.0x 4.0x 3.0x 2.0x 1.0x 0.0x DATA SOURCE: HEDGEYE TRACKER HEDGEYE 20

21 ATHN HISTORICAL EV/SALES NTM 10.0x EV/Sales NTM Average +1 Std Dev -1 Std Dev 9.0x 8.0x NTM EV/Sales 7.0x 6.0x 5.0x 4.0x 3.0x 2.0x HEDGEYE 21

22 APPENDIX

23 BIOTECH EMPLOYMENT 8.0% Employment - Biotechnology research y/y growth % 6.0% April +4.9% 4.0% 2.0% - (2.0%) (4.0%) (6.0%) DATA SOURCE: BLS HEDGEYE 23

24 OFFICE OF PHYSICIANS EMPLOYMENT 4.0% Employment - Offices of physicians y/y growth % 3.5% 3.0% 2.5% May +3.0% 2.0% 1.5% 1.0% 0.5% - DATA SOURCE: BLS HEDGEYE 24

25 HEALTHCARE JOB OPENINGS (JOLTS) 70.0% 60.0% 50.0% JOLTS: Health Care and Social Assistance - Job Openings y/y growth % 2-Yr Average Rolling 12-mo Average 40.0% 30.0% 20.0% 10.0% 0.0% -10.0% -20.0% -30.0% -40.0% DATA SOURCE: BLS HEDGEYE 25

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE HEDGEYE 1 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment

More information

DISCLAIMER DISCLAIMER

DISCLAIMER DISCLAIMER DISCLAIMER DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE HEDGEYE 1 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment

More information

HEALTHCARE THEMES CALL

HEALTHCARE THEMES CALL THOMAS TOBIN MANAGING DIRECTOR @HedgeyeHC ANDREW FREEDMAN ANALYST @ HedgeyeHIT HEALTHCARETEAM@HEDGEYE.COM (203) 562-6500 HEALTHCARE THEMES CALL JULY 14 TH, 2016 AT 11:00 M ET HEDGEYE 1 LEGAL DISCLAIMER

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

Hedgeye Risk Management LLC. All Rights Reserved.

Hedgeye Risk Management LLC. All Rights Reserved. THOMAS TOBIN MANAGING DIRECTOR @HedgeyeHC EMILY EVANS MANAGING DIRECTOR @HedgeyeEEvans ANDREW FREEDMAN, CFA ASSOCIATE @HedgeyeHIT ALEX ROSS ANALYST @HedgeyeLab 1 DISCLAIMER DISCLAIMER Hedgeye Risk Management

More information

The Macro Show. Hedgeye Risk Management LLC

The Macro Show. Hedgeye Risk Management LLC Hedgeye Risk Management LLC LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does

More information

THE GIG ECONOMY IS ALIVE AND GROWING

THE GIG ECONOMY IS ALIVE AND GROWING ABOUT EVERYTHING WITH NEIL HOWE THE GIG ECONOMY IS ALIVE AND GROWING THE NUMBER OF U.S. WORKERS WITH IRREGULAR JOBS IS INCREASING. August 9, 2016 LEGAL DISCLAIMER Hedgeye Risk Management is a registered

More information

The Macro Show. Hedgeye Risk Management LLC

The Macro Show. Hedgeye Risk Management LLC Hedgeye Risk Management LLC LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does

More information

U.S. ECONOMIC UPDATE. MACRO February 5, 2014

U.S. ECONOMIC UPDATE. MACRO February 5, 2014 U.S. ECONOMIC UPDATE MACRO February 5, 2014 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker

More information

HOWARD PENNEY FRED MASOTTA PANERA BREAD COMPANY FLASH CALL: THE ACTIVIST PLAYBOOK APRIL 17, 2015

HOWARD PENNEY FRED MASOTTA PANERA BREAD COMPANY FLASH CALL: THE ACTIVIST PLAYBOOK APRIL 17, 2015 HOWARD PENNEY FRED MASOTTA PANERA BREAD COMPANY FLASH CALL: THE ACTIVIST PLAYBOOK APRIL 17, 2015 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

The Macro Show. Hedgeye Risk Management LLC

The Macro Show. Hedgeye Risk Management LLC Hedgeye Risk Management LLC LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does

More information

1Q14 MACRO THEMES MACRO TEAM. Updated for March 19, 2014

1Q14 MACRO THEMES MACRO TEAM. Updated for March 19, 2014 1Q14 MACRO THEMES MACRO TEAM Updated for March 19, 2014 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is

More information

Coker Capital s June 2017 Newsletter: Eye Care Sector Update

Coker Capital s June 2017 Newsletter: Eye Care Sector Update Healthcare M&A Advisory Coker Capital s June 2017 Newsletter: Eye Care Sector Update Executive Summary The eye care industry in the United States generated approximately $36 billion in revenue in 2015.

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

LEGAL DISCLAIMER TERMS OF USE

LEGAL DISCLAIMER TERMS OF USE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment advice

More information

MACAU PREMIUM MASS THE STANDOUT NOVEMBER 9, 2016

MACAU PREMIUM MASS THE STANDOUT NOVEMBER 9, 2016 TEAM TODD MEMBER JORDAN ONE TEAM SEAN MEMBER JENKINS TWO FELIX TEAM MEMBER WANG, CFA THREE TEAM MEMBER FOUR MACAU PREMIUM MASS THE STANDOUT NOVEMBER 9, 2016 DISCLAIMER DISCLAIMER Hedgeye Risk Management

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target

More information

Healthcare M&A Report Q3 2016

Healthcare M&A Report Q3 2016 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383 0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383 0206 Keith Hodgdon Managing Director hodgdon@hydeparkcapital.com

More information

ACTUALLY, VALUATION IS NOT A CATALYST

ACTUALLY, VALUATION IS NOT A CATALYST Hedgeye CEO & Founder: Keith McCullough ACTUALLY, VALUATION IS NOT A CATALYST November 7 th, 2017 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State

More information

Hedgeye Risk Management LLC. All Rights Reserved.

Hedgeye Risk Management LLC. All Rights Reserved. DISCLAIMER DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management is not a broker dealer and does not provide investment

More information

MACAU REVIEW AND OUTLOOK SHORT TERM GAIN, LONG TERM????

MACAU REVIEW AND OUTLOOK SHORT TERM GAIN, LONG TERM???? MACAU REVIEW AND OUTLOOK SHORT TERM GAIN, LONG TERM???? GAMING/LODGING/LEISURE TEAM (Todd Jordan and Felix Wang) October 8, 2015 LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor,

More information

RBC Capital Markets Corp. Bill Bonello (Analyst) (612) ; bbonellorbccm

RBC Capital Markets Corp. Bill Bonello (Analyst) (612) ; bbonellorbccm EQUITY I RESEARCH In Vitro Diagnostics (IVD) A Wall Street Perspective Executive War College April 28, 2010 RBC Capital Markets Corp. Bill Bonello (Analyst) (612) 313-1212; bill.bonello@rbccm.com; bbonellorbccm

More information

HEALTHCARE MARKET REPORT FY2016

HEALTHCARE MARKET REPORT FY2016 HEALTHCARE MARKET REPORT FY2016 FY2016 OVERALL MARKET UPDATE AND ECONOMIC REVIEW FY2016 M&A UPDATE Empirically, M&A activity appears to be slowing. For the year, total transaction value was essentially

More information

athenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY

athenahealth Inc. NEUTRAL ZACKS CONSENSUS ESTIMATES (ATHN-NASDAQ) SUMMARY February 10, 2015 athenahealth Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 10/23/2011 Current Price (02/09/15) $136.28 Target Price $143.00 52-Week

More information

MACAU VISIT TAKEAWAYS AND WEEKLY ANALYSIS Some hope emerging

MACAU VISIT TAKEAWAYS AND WEEKLY ANALYSIS Some hope emerging MACAU VISIT TAKEAWAYS AND WEEKLY ANALYSIS Some hope emerging MARCH 30, 2015 Todd Jordan tjordan@hedgeye.com Felix Wang, CFA fwang@hedgeye.com HEDGEYE.COM MARCH 30, 2015 1 CALL TO ACTION With in-line weekly

More information

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: PHYSICIAN SERVICES. September 2016 COKER CAPITAL ADVISORS SEPTEMBER 2016

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: PHYSICIAN SERVICES. September 2016 COKER CAPITAL ADVISORS SEPTEMBER 2016 MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: PHYSICIAN SERVICES SEPTEMBER 2016 Physician Services: M&A Market Update Over the past five years, physician services has become one of the most active sectors

More information

JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA LAZARD (LAZ) CYCLICAL COMPANY MODELED AS SECULAR. January 2016

JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA LAZARD (LAZ) CYCLICAL COMPANY MODELED AS SECULAR. January 2016 JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA LAZARD (LAZ) CYCLICAL COMPANY MODELED AS SECULAR January 2016 DISCLAIMER DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with

More information

Healthcare IT Weekly EQUITY RESEARCH INDUSTRY UPDATE. September 19, 2016 HEALTHCARE/HEALTHCARE IT & DISTRIBUTION

Healthcare IT Weekly EQUITY RESEARCH INDUSTRY UPDATE. September 19, 2016 HEALTHCARE/HEALTHCARE IT & DISTRIBUTION EQUITY RESEARCH INDUSTRY UPDATE September 19, 2016 HEALTHCARE/HEALTHCARE IT & DISTRIBUTION Healthcare IT Weekly SUMMARY Last week was fairly quiet on most fronts. Payer spend in 2Q rose at Hospitals (+6.6%

More information

JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA T. ROWE PRICE (TROW) PADDLING UPSTREAM BEST IDEAS SHORT. March 2016

JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA T. ROWE PRICE (TROW) PADDLING UPSTREAM BEST IDEAS SHORT. March 2016 JONATHAN CASTELEYN, CFA JOSHUA STEINER, CFA T. ROWE PRICE (TROW) PADDLING UPSTREAM BEST IDEAS SHORT March 2016 DISCLAIMER DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered

More information

Healthcare M&A Report Q1 2014

Healthcare M&A Report Q1 2014 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Keith Hodgdon Senior Vice President hodgdon@hydeparkcapital.com

More information

Thought Leadership Panel: What s the Matter with MLP Non-GAAP Metrics?

Thought Leadership Panel: What s the Matter with MLP Non-GAAP Metrics? Thought Leadership Panel: What s the Matter with MLP Non-GAAP Metrics? February 26, 2014 CFRA Julie Hilt Hannink, CFA +646.517-2462 JulieHilt.Hannink@cfraresearch.com Hedgeye Risk Management Kevin Kaiser

More information

HCIT MIDDLE-MARKET UPDATE 2Q2018

HCIT MIDDLE-MARKET UPDATE 2Q2018 HCIT MIDDLE-MARKET UPDATE 2Q218 2Q 218 OVERALL MARKET UPDATE AND ECONOMIC REVIEW Middle-market M&A activity slowed dramatically during the first half of218 in both the number and value of transactions.

More information

Healthcare M&A Report Q1 2015

Healthcare M&A Report Q1 2015 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383 0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383 0206 Keith Hodgdon Managing Director hodgdon@hydeparkcapital.com

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to

More information

Presentation Overview

Presentation Overview 2012 VMG Health Reading the Tea Leaves Assessing ASC Valuation Trends Utilizing the Latest Industry Data ELLIOTT JETER, C F A, C PA /ABV P A R T N E R C OLIN MCDERMOTT, C F A, C PA /ABV S E N I O R M A

More information

Quarterly Healthcare Market Report

Quarterly Healthcare Market Report Quarterly Healthcare Market Report 2Q14 & 3Q14 5000 Meridian Blvd, Suite 350, Franklin, TN 37067 Phone: (615) 224-3830 www.brentwoodcapital.com Transaction Volume 2Q14 & 3Q14 Overall Market Update and

More information

OCTOBER 27, geye.com

OCTOBER 27, geye.com GLPI: Q3 2014 EARNINGS PREP OCTOBER 27, 2014 Todd Jordan tjordan@hedg geye.com David Benz dbenz@hedgeye.com Felix Wang, CFA fwang@hedgeye.com 1 HEDGEYE Q3 2014 ESTIMATES Adjusted EBITDA: $106 million FFO:

More information

Healthcare IT Insights

Healthcare IT Insights Healthcare IT Insights J U LY 2 0 1 8 Is Blockchain Hope or Hype for Improving Revenue Cycle Management and Healthcare? When most think of blockchain, they think of Bitcoin, the cryptocurrency that has

More information

COMPANY PRESENTATION - HEALTHCARE. Anthony Rogers, Thomas Rosol & Dylan Seymour

COMPANY PRESENTATION - HEALTHCARE. Anthony Rogers, Thomas Rosol & Dylan Seymour COMPANY PRESENTATION - HEALTHCARE Anthony Rogers, Thomas Rosol & Dylan Seymour Agenda Overview Business Analysis Financial Analysis Valuation Analysis Company Analysis Recommendation 2 S&P 500 Sector Weight

More information

Healthcare M&A Report Q4 2013

Healthcare M&A Report Q4 2013 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Keith Hodgdon Senior Vice President hodgdon@hydeparkcapital.com

More information

HOSPITALS. Updating Models Post Q1, 2019 Setting Up Well for HCA HEALTHCARE SERVICES

HOSPITALS. Updating Models Post Q1, 2019 Setting Up Well for HCA HEALTHCARE SERVICES HEALTHCARE SERVICES Healthcare Facilities Market Weight HOSPITALS Updating Models Post Q1, 2019 Setting Up Well for HCA Updating Models Following 1Q18 earnings we are updating estimates and price targets

More information

Cerner Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (CERN-NASDAQ) SUMMARY

Cerner Corporation NEUTRAL ZACKS CONSENSUS ESTIMATES (CERN-NASDAQ) SUMMARY January 29, 2015 Cerner Corporation Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 08/01/2012 Current Price (01/28/15) $66.87 Target Price $70.00 52-Week

More information

Healthcare M&A Report Q3 2012

Healthcare M&A Report Q3 2012 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Keith Hodgdon Senior Vice President hodgdon@hydeparkcapital.com

More information

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: SPECIALTY TOXICOLOGY LAB SERVICES APRIL 2016 COKER CAPITAL ADVISORS APRIL 2016

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: SPECIALTY TOXICOLOGY LAB SERVICES APRIL 2016 COKER CAPITAL ADVISORS APRIL 2016 MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: SPECIALTY TOXICOLOGY LAB SERVICES APRIL 2016 Specialty Toxicology Lab Services Sector Overview Companies in the specialty toxicology lab services sector

More information

NOVEMBER 11, Todd Jordan

NOVEMBER 11, Todd Jordan RHP: GROUP LODGING A BRIGHT FUTURE NOVEMBER 11, 2014 Todd Jordan tjordan@ @hedgeye.com David Benz dbenz@hedgeye.com Felix Wang, CFA fwang@hedgeye.com 1 CALL TO ACTION RHP has traded roughly flat (better

More information

Syneos Health, Inc. Investment Research Presentation

Syneos Health, Inc. Investment Research Presentation Syneos Health, Inc. Investment Research Presentation NasdaqGS: SYNH Month Sector: Day, Healthcare 20XX Senior Analyst: Jose Grullon Junior Analysts: Garbis Chekerdjian, Ignacio Fimbres Spring 2018 1 Valuation

More information

Hedgeye Best Ideas Conference Call

Hedgeye Best Ideas Conference Call Hedgeye Best Ideas Conference Call Friday, November 11, 2011 THIS PRESENTATION WAS PREPARED BY: THE HEDGEYE RISK MANAGEMENT RESEARCH TEAM Disclaimer Hedgeye Risk Management is not a broker dealer and does

More information

TECHNOLOGY SERVICES MONTHLY January Arch Street, 39th Floor Philadelphia, PA

TECHNOLOGY SERVICES MONTHLY January Arch Street, 39th Floor Philadelphia, PA TECHNOLOGY SERVICES MONTHLY January 2017 1717 Arch Street, 39th Floor Philadelphia, PA 19103 www.mhhco.com TECHNOLOGY SERVICES MONTHLY Welcome to the MHH Technology Newsletter! Welcome to the inaugural

More information

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2015 COKER CAPITAL ADVISORS JULY 2015

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2015 COKER CAPITAL ADVISORS JULY 2015 MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2015 Eating Disorder Treatment Sector Overview and Update Against a backdrop of favorable market conditions and positive tailwinds

More information

First Trust AlphaDEX TM U.S. Health Care Sector Index ETF

First Trust AlphaDEX TM U.S. Health Care Sector Index ETF First Trust AlphaDEX TM U.S. Health Care Sector Index ETF Interim June 30, 2015 INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE June 30, 2015 (the First Trust ETF ) This interim management report of fund

More information

CRI MARGIN REBOUND DISCONNECT OCTOBER

CRI MARGIN REBOUND DISCONNECT OCTOBER CRI MARGIN REBOUND DISCONNECT OCTOBER 15 2012 DISCLAIMER Hedgeye Risk Management is not a broker dealer and does not make investment recommendations. This presentation does not constitute an offer to sell,

More information

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2016 COKER CAPITAL ADVISORS JULY 2016

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2016 COKER CAPITAL ADVISORS JULY 2016 MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: EATING DISORDER TREATMENT JULY 2016 One Year Look Back: Eating Disorder Treatment In this month s sector spotlight, Coker Capital revisits the eating disorder

More information

ATHENAHEALTH. TEAM Christopher Dunn David Vercoutere Braden Weinstock. ADVISORS Professor Patrick J. Schena Vitaly Veksler, CFA

ATHENAHEALTH. TEAM Christopher Dunn David Vercoutere Braden Weinstock. ADVISORS Professor Patrick J. Schena Vitaly Veksler, CFA ATHENAHEALTH A STORY OF OVERVALUED GROWTH TEAM Christopher Dunn David Vercoutere Braden Weinstock ADVISORS Professor Patrick J. Schena Vitaly Veksler, CFA Boston - February 10, 2014 Stock Price ($) Overview

More information

Anatomic Pathology: A Wall Street Perspective

Anatomic Pathology: A Wall Street Perspective A publication of Wachovia Capital Markets, LLC Anatomic Pathology: A Wall Street Perspective Bill Bonello Senior Research Analyst Managing Director 612-342-0789 bill.bonello@wachovia.com WCM does and seeks

More information

Healthcare Information Technology

Healthcare Information Technology Healthcare Information Technology INDUSTRY INSIGHTS JANUARY 2018 CONTENTS 1 Addressing the Challenges of Patient Receivables 4 2017 HCIT M&A Overview 5 M&A Activity HCIT Trends 8 HCIT IPO Activity 9 Public

More information

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: DENTAL SERVICES AUGUST 2015 COKER CAPITAL ADVISORS AUGUST 2015

MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: DENTAL SERVICES AUGUST 2015 COKER CAPITAL ADVISORS AUGUST 2015 MONTHLY HEALTHCARE M&A UPDATE SECTOR SPOTLIGHT: DENTAL SERVICES AUGUST 2015 Dental Services Overview and Update Dental services (including dental practice management) is a $123 billion industry with expected

More information

A Compelling Opportunity to Create Shareholder Value

A Compelling Opportunity to Create Shareholder Value A Compelling Opportunity to Create Shareholder Value October 20, 2015 Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

-2.3% 13.4% 2.7x. 23.5x. 21.7x. 31.2x. Online Review Sites. Public Company Key Statistics

-2.3% 13.4% 2.7x. 23.5x. 21.7x. 31.2x. Online Review Sites. Public Company Key Statistics Q2: Quarterly Industry Update AS OF JUNE 30, 2017 Online Review Sites INDUSTRY SUMMARY COGENT VALUATION identified Online Review Sites publicly traded companies, IPOs, and recent M&A transactions within

More information

TECHNOLOGY SERVICES MONTHLY Franchise Themes

TECHNOLOGY SERVICES MONTHLY Franchise Themes TECHNOLOGY SERVICES MONTHLY Franchise Themes January 2018 1717 Arch Street, 39th Floor Philadelphia, PA 19103 www.mhhco.com TECHNOLOGY SERVICES MONTHLY Welcome to the MHH Technology Newsletter! Welcome

More information

Health Care Facilities

Health Care Facilities Page 1 of 5 INDUSTRY NOTE USA Healthcare Health Care Facilities July 21, 2014 Health Care Facilities Hospital Survey: Inpatient Volumes Were Positive; Expect More Doc Outsourcing Key Takeaway We conducted

More information

TECHNOLOGY SERVICES MONTHLY ELECTRONIC HEALTH RECORDS

TECHNOLOGY SERVICES MONTHLY ELECTRONIC HEALTH RECORDS TECHNOLOGY SERVICES MONTHLY ELECTRONIC HEALTH RECORDS June 2018 1717 Arch Street, 39th Floor Philadelphia, PA 19103 www.mhhco.com TECHNOLOGY SERVICES MONTHLY Welcome to the MHH Technology Newsletter! Welcome

More information

Stryker Corp. Post-4Q15 Thoughts

Stryker Corp. Post-4Q15 Thoughts EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float

More information

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy 23-Apr-14 14-May-14 4-Jun-14 25-Jun-14 16-Jul-14 6-Aug-14 27-Aug-14 17-Sep-14 8-Oct-14 29-Oct-14 19-Nov-14 10-Dec-14 31-Dec-14 21-Jan-15 11-Feb-15 4-Mar-15 25-Mar-15 15-Apr-15 Daily Volume ('000) Share

More information

Attractiveness of the Behavioral Health Market: Understanding Valuations, Trends and Growth

Attractiveness of the Behavioral Health Market: Understanding Valuations, Trends and Growth Attractiveness of the Behavioral Health Market: Understanding Valuations, Trends and Growth Session #102, March 7, 2018 Matthew M. Dorman, Credible Behavioral Health, CEO Jason Kreuziger, Goldman Sachs

More information

Model Updates. March 15, Healthcare Services & Distribution MORGAN STANLEY RESEARCH. Ashley E Ponce

Model Updates. March 15, Healthcare Services & Distribution MORGAN STANLEY RESEARCH. Ashley E Ponce March 15, 2016 LH + DGX Model Updates We are updating our models and extending estimates to 2018 - when we think PAMA will likely affect pricing vs. previous estimate of 2017. Trim LH PT to $133, remain

More information

BOK Financial U.S. Economic and Market Outlook

BOK Financial U.S. Economic and Market Outlook BOK Financial U.S. Economic and Market Outlook 2016 Oklahoma Economic Outlook Conference Oklahoma City Tuesday, December 8, 2015 Jim Huntzinger, Chief Investment Officer BOK Financial Corporation Labor

More information

Investment Banking I Industry Spotlight

Investment Banking I Industry Spotlight Investment Banking I Industry Spotlight Healthcare I 1 Healthcare Group Overview Fifth Third is a leading provider of Corporate and Investment Banking Advisory Services to the Healthcare Industry, with

More information

Royce Premier Fund IMPACT AND ATTRIBUTION REPORT INVESTMENT CLASS

Royce Premier Fund IMPACT AND ATTRIBUTION REPORT INVESTMENT CLASS FINANCIAL PROFESSIONALS ONLY Royce Premier Fund IMPACT AND ATTRIBUTION REPORT INVESTMENT CLASS March 31, 2018 Royce Premier Fund IMPACT AND ATTRIBUTION REPORT 2 Performance Performance and Expenses (%)

More information

MACRO PLAYBOOK DARIUS DALE: MACRO TEAM

MACRO PLAYBOOK DARIUS DALE: MACRO TEAM MACRO PLAYBOOK DARIUS DALE: MACRO TEAM APRIL 22, 2015 UPDATE LEGAL DISCLAIMER Hedgeye Risk Management is a registered investment advisor, registered with the State of Connecticut. Hedgeye Risk Management

More information

Allscripts Healthcare Solutions

Allscripts Healthcare Solutions Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Healthcare M&A Report Q3 2018

Healthcare M&A Report Q3 2018 Integrity Expertise Results Overview Nationally recognized and well-established investment bank founded in 2000 Over 300 transactions completed, totaling more than $10 billion in transaction value Extensive

More information

Tenet Healthcare Corp.

Tenet Healthcare Corp. March 04, 2015 Tenet Healthcare Corp. Current Recommendation Prior Recommendation Neutral Date of Last Change 03/04/2015 Current Price (03/03/15) $47.06 Target Price $43.00 UNDERPERFORM (THC-NYSE) SUMMARY

More information

Trailing PE Forward PE Hold 18 Analysts. 1-Year Return: 28.7% 5-Year Return: 63.9%

Trailing PE Forward PE Hold 18 Analysts. 1-Year Return: 28.7% 5-Year Return: 63.9% VENTAS INC (-N) Last Close 71.91 (USD) Avg Daily Vol 2.8M 52-Week High 76.80 Trailing PE 55.3 Annual Div 2.92 ROE 4.3% LTG Forecast -- 1-Mo -2.3% September 29, 2016 NEW YORK Exchange Market Cap 25.4B 52-Week

More information

Analyst s Handbook: Health Care

Analyst s Handbook: Health Care Analyst s Handbook: November 17, 217 Dr. Edward Yardeni 16-972-7683 eyardeni@ Mali Quintana 48-664-1333 aquintana@ Please visit our sites at www. blog. thinking outside the box Table Of Contents Table

More information

2017 Oklahoma State University Economic Outlook Conference Tuesday, December 6, 2016 Brian Henderson, President Cavanal Hill Investment Management

2017 Oklahoma State University Economic Outlook Conference Tuesday, December 6, 2016 Brian Henderson, President Cavanal Hill Investment Management 2017 Oklahoma State University Economic Outlook Conference Tuesday, December 6, 2016 Brian Henderson, President Cavanal Hill Investment Management Labor Market Vastly Improved Civilian Unemployment Rate:

More information

Trailing PE 4.8. Forward PE 8.6. Buy 2 Analysts. 1-Year Return: -10.6% 5-Year Return: 61.4%

Trailing PE 4.8. Forward PE 8.6. Buy 2 Analysts. 1-Year Return: -10.6% 5-Year Return: 61.4% MORGUARD CORP (-T) Last Close 167.20 (CAD) Avg Daily Vol 1,962 52-Week High 194.10 Trailing PE 4.8 Annual Div 0.60 ROE 13.6% LTG Forecast -- 1-Mo -1.4% 2018 June 15 TORONTO Exchange Market Cap 1.9B 52-Week

More information

Honeywell Automation India Ltd

Honeywell Automation India Ltd 4 Recommendation SUBSCRIBE SUBSCRIBE FROM A LONG TERM VIEW CMP (14/12/2012) Rs. 2,335 Target Price Sector Stock Details N/A Automation BSE Code 500033 NSE Code Bloomberg Code HONAUT HWA IN Market Cap (Rs

More information

Trailing PE -- Forward PE Buy 6 Analysts. 1-Year Return: -5.7% 5-Year Return: 710.7%

Trailing PE -- Forward PE Buy 6 Analysts. 1-Year Return: -5.7% 5-Year Return: 710.7% ING GROUP (-AE) Last Close 0.95 (EUR) Avg Daily Vol 11.9M 52-Week High 1.62 Trailing PE -- Annual Div -- ROE -112.3% LTG Forecast -- 1-Mo 1.9% November 01 AMSTERDAM Exchange Market Cap 551M 52-Week Low

More information

Market Capitalization $6.3 Billion

Market Capitalization $6.3 Billion BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY SDAQ: ICLR BUY RATING SINCE 03/26/2013 TARGET PRICE $151.83 ICLR BUSINESS DESCRIPTION ICON Public Limited Company, a contract

More information

The Compelling Case for Value

The Compelling Case for Value The Compelling Case for Value July 2, 2018 SOLELY FOR THE USE OF INSTITUTIONAL INVESTORS AND PROFESSIONAL ADVISORS 0 Jan-75 Jan-77 Jan-79 Jan-81 Jan-83 Jan-85 Jan-87 Jan-89 Jan-91 Jan-93 Jan-95 Jan-97

More information

Investment Rationale/Risk

Investment Rationale/Risk Recommendation HOLD Equity Analyst Kevin Huang, CFA Price $92.34 (as of Dec 06, 2018 4:00 PM ET) 12-Mo. Target Price $109.00 Report Currency USD GICS Sector Health Care Sub-Industry Health Care Technology

More information

Trailing PE Forward PE Hold 6 Analysts. 1-Year Return: 3.5% 5-Year Return: 21.4%

Trailing PE Forward PE Hold 6 Analysts. 1-Year Return: 3.5% 5-Year Return: 21.4% Last Close 11.73 (CAD) Avg Daily Vol 961,084 52-Week High 11.84 Trailing PE 25.3 Annual Div 0.80 ROE 6.9% LTG Forecast -- 1-Mo 8.4% 2019 March 26 TORONTO Exchange Market Cap 1.4B 52-Week Low 9.27 Forward

More information

Corporate Finance Topics Q Investing in Growth

Corporate Finance Topics Q Investing in Growth Corporate Finance Topics Q3 2013 Investing in Growth As the economy continues to improve, we believe corporate leaders must reassess capital allocation and develop a strategy to maximize returns. As the

More information

HCA HOLDINGS, INC. Conference Call Takeaways HEALTHCARE SERVICES. (HCA $ Outperform)

HCA HOLDINGS, INC. Conference Call Takeaways HEALTHCARE SERVICES. (HCA $ Outperform) 07-17 09-17 11-17 01-18 03-18 05-18 07-18 HEALTRE SERVICES Healthcare Facilities Market Weight HOLDINGS, INC. ( $108.16 Outperform) Conference Call Takeaways Core Growth Accelerated in Q2 Solid volume

More information

LARGE CAP & 1,970 BSE

LARGE CAP & 1,970 BSE Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)

More information

Market Capitalization $7.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years

Market Capitalization $7.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BIO BUSINESS DESCRIPTION Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical

More information

Washington & The Investment Landscape Daniel Clifton February 2019 Macro Research

Washington & The Investment Landscape Daniel Clifton February 2019 Macro Research Washington & The Investment Landscape Daniel Clifton February 2019 Macro Research Investment Strategy Economics Policy Research Quantitative Research Technical Research Fixed Income Research Industry Surveys

More information

R e t r e a t s & R e c o v e r i e s. S a m S t o v a l l, J u l y 2 5,

R e t r e a t s & R e c o v e r i e s. S a m S t o v a l l, J u l y 2 5, R e t r e a t s & R e c o v e r i e s S a m S t o v a l l, J u l y 2 5, 2 0 1 7 Stock Market Headwinds & Tailwinds Headwinds Aging bull market & elevated equity valuations Aging economic cycle & rising

More information

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months. 1QFY213 Result Update Airlines July 31, 212 SpiceJet Performance Highlights Particulars (` cr) 1QFY213 1QFY212 %chg (yoy) 4QFY212 %chg (qoq) Net sales 1,467 946 55.1 1,113 31.8 EBITDA 76 (67) 214 (2) 138

More information

Havells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY.

Havells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY. Havells India Q3FY17 Result Update Positive surprise; Maintain Buy Sector: Consumer Durable CMP: ` 376 Recommendation: BUY Market statistics Current stock price (`) 376 Shares O/S (cr.) 62.5 Mcap (` cr)

More information

Portfolio Strategy Weekly Audio: Time to Focus on ROE A Stable Growth Update

Portfolio Strategy Weekly Audio: Time to Focus on ROE A Stable Growth Update Portfolio Strategy Weekly Audio: Time to Focus on ROE A Stable Growth Update A 5 Minute Audio Brief Chris Senyek, CFA, CPA Head of Macro Research Chief Investment Strategist 646-845-0759 CSenyek@wolferesearch.com

More information

Analyst s Handbook: Health Care

Analyst s Handbook: Health Care Analyst s Handbook: ober 22, 212 Dr. Edward Yardeni 16-972-7683 eyardeni@ Mali Quintana 48-664-1333 aquintana@ Please visit our sites at www. blog. thinking outside the box Table Of Contents Table Of Contents

More information

TECHNOLOGY SERVICES MONTHLY: Managed Service Providers

TECHNOLOGY SERVICES MONTHLY: Managed Service Providers TECHNOLOGY SERVICES MONTHLY: Managed Service Providers March 2017 1717 Arch Street, 39th Floor Philadelphia, PA 19103 www.mhhco.com TECHNOLOGY SERVICES MONTHLY Welcome to the MHH Technology Newsletter!

More information

Trailing PE Forward PE -- NA 0 Analysts. 1-Year Return: 0.0% 5-Year Return: -78.1%

Trailing PE Forward PE -- NA 0 Analysts. 1-Year Return: 0.0% 5-Year Return: -78.1% Last Close 1.10 (CAD) Avg Daily Vol 13,433 52-Week High 1.35 Trailing PE 275.0 Annual Div ROE -5.2% LTG Forecast 1-Mo 19.6% 2019 April 05 TSX VENTURE Exchange Market Cap 24M 52-Week Low 0.69 Forward PE

More information

Titan Industries. CMP: INR222 TP: INR220 Neutral

Titan Industries. CMP: INR222 TP: INR220 Neutral BSE SENSEX S&P CNX 17,257 5,241 Bloomberg TTAN IN Equity Shares (m) 887.8 52-Week Range (INR) 255/154 1,6,12 Rel. Perf. (%) -1/13/3 M.Cap. (Rs b) 197.1 M.Cap. (US$ b) 3.6 2 August 2012 1QFY13 Results Update

More information